PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE DEFICIENCY

Clinical trials for PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE DEFICIENCY trials appear

Sign up with your email to follow new studies for PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with rare seizure disorder: vitamin B6 therapy in final testing phase

Disease control Recruiting now

This study tests an oral form of pyridoxal 5'-phosphate (P5P), a vitamin B6 derivative, for people with a rare genetic condition called PNPO deficiency. The condition causes hard-to-control seizures. The study will enroll 15 patients aged 2 years and older who already take P5P to…

Matched conditions: PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE DEFICIENCY

Phase: PHASE3 • Sponsor: Medicure • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE DEFICIENCY

Get alerted when new PYRIDOX(AM)INE 5'-PHOSPHATE OXIDASE DEFICIENCY trials appear

New hope for kids with rare seizure disorder: vitamin B6 therapy in final testing phase